Cargando…
The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
Brain-derived neurotrophic factor (BDNF) is a growth factor synthesized in the cell bodies of neurons and glia, which affects neuronal maturation, the survival of nervous system, and synaptic plasticity. BDNF play an important role in the pathophysiology of major depression (MD). The serum BDNF leve...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953440/ https://www.ncbi.nlm.nih.gov/pubmed/36831119 http://dx.doi.org/10.3390/biomedicines11020584 |
_version_ | 1784893878329933824 |
---|---|
author | Yoshimura, Reiji Okamoto, Naomichi Chibaatar, Enkmurun Natsuyama, Tomoya Ikenouchi, Atsuko |
author_facet | Yoshimura, Reiji Okamoto, Naomichi Chibaatar, Enkmurun Natsuyama, Tomoya Ikenouchi, Atsuko |
author_sort | Yoshimura, Reiji |
collection | PubMed |
description | Brain-derived neurotrophic factor (BDNF) is a growth factor synthesized in the cell bodies of neurons and glia, which affects neuronal maturation, the survival of nervous system, and synaptic plasticity. BDNF play an important role in the pathophysiology of major depression (MD). The serum BDNF levels changed over time, or with the improvement in depressive symptoms. However, the change of serum BDNF during pharmacotherapy remains obscure in MDD. In particular, the changes in serum BDNF associated with pharmacotherapy have not yet been fully elucidated. The present study aimed to compare the changes in serum BDNF concentrations in first-episode, drug-naive patients with MD treated with antidepressants between treatment-response and treatment-nonresponse groups. The study included 35 inpatients and outpatients composed of 15 males and 20 females aged 36.7 ± 6.8 years at the Department of Psychiatry of our University Hospital. All patients met the DSM-5 diagnostic criteria for MD. The antidepressants administered included paroxetine, duloxetine, and escitalopram. Severity of depressive state was assessed using the 17-item HAMD before and 8 weeks after drug administration. Responders were defined as those whose total HAMD scores at 8 weeks had decreased by 50% or more compared to those before drug administration, while non-responders were those whose total HAMD scores had decreased by less than 50%. Here we showed that serum BDNF levels were not significantly different at any point between the two groups. The responder group, but not the non-responder group, showed statistically significant changes in serum BDNF 0 and serum BDNF 8. The results suggest that the changes of serum BDNF might differ between the two groups. The measurement of serum BDNF has the potential to be a useful predictor of pharmacotherapy in patients with first-episode, drug-naïve MD. |
format | Online Article Text |
id | pubmed-9953440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99534402023-02-25 The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression Yoshimura, Reiji Okamoto, Naomichi Chibaatar, Enkmurun Natsuyama, Tomoya Ikenouchi, Atsuko Biomedicines Article Brain-derived neurotrophic factor (BDNF) is a growth factor synthesized in the cell bodies of neurons and glia, which affects neuronal maturation, the survival of nervous system, and synaptic plasticity. BDNF play an important role in the pathophysiology of major depression (MD). The serum BDNF levels changed over time, or with the improvement in depressive symptoms. However, the change of serum BDNF during pharmacotherapy remains obscure in MDD. In particular, the changes in serum BDNF associated with pharmacotherapy have not yet been fully elucidated. The present study aimed to compare the changes in serum BDNF concentrations in first-episode, drug-naive patients with MD treated with antidepressants between treatment-response and treatment-nonresponse groups. The study included 35 inpatients and outpatients composed of 15 males and 20 females aged 36.7 ± 6.8 years at the Department of Psychiatry of our University Hospital. All patients met the DSM-5 diagnostic criteria for MD. The antidepressants administered included paroxetine, duloxetine, and escitalopram. Severity of depressive state was assessed using the 17-item HAMD before and 8 weeks after drug administration. Responders were defined as those whose total HAMD scores at 8 weeks had decreased by 50% or more compared to those before drug administration, while non-responders were those whose total HAMD scores had decreased by less than 50%. Here we showed that serum BDNF levels were not significantly different at any point between the two groups. The responder group, but not the non-responder group, showed statistically significant changes in serum BDNF 0 and serum BDNF 8. The results suggest that the changes of serum BDNF might differ between the two groups. The measurement of serum BDNF has the potential to be a useful predictor of pharmacotherapy in patients with first-episode, drug-naïve MD. MDPI 2023-02-16 /pmc/articles/PMC9953440/ /pubmed/36831119 http://dx.doi.org/10.3390/biomedicines11020584 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoshimura, Reiji Okamoto, Naomichi Chibaatar, Enkmurun Natsuyama, Tomoya Ikenouchi, Atsuko The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title | The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title_full | The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title_fullStr | The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title_full_unstemmed | The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title_short | The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression |
title_sort | serum brain-derived neurotrophic factor increases in serotonin reuptake inhibitor responders patients with first-episode, drug-naïve major depression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953440/ https://www.ncbi.nlm.nih.gov/pubmed/36831119 http://dx.doi.org/10.3390/biomedicines11020584 |
work_keys_str_mv | AT yoshimurareiji theserumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT okamotonaomichi theserumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT chibaatarenkmurun theserumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT natsuyamatomoya theserumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT ikenouchiatsuko theserumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT yoshimurareiji serumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT okamotonaomichi serumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT chibaatarenkmurun serumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT natsuyamatomoya serumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression AT ikenouchiatsuko serumbrainderivedneurotrophicfactorincreasesinserotoninreuptakeinhibitorresponderspatientswithfirstepisodedrugnaivemajordepression |